Indefinite Delivery Contract HHSN268201600015I

The National Institutes of Health (NIH) Clinical Center awarded a single-award Indefinite Delivery Contract (IDC) to Miltenyi Biotec, Inc., a global biotechnology company, to provide proprietary CliniMACS cell isolation reagents and consumables. The $4.6 million contract has an initial base period through September 2025, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing...

The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), has awarded a series of delivery order contracts to the American Type Culture Collection (ATCC), a nonprofit biological resource center, under an Indefinite Delivery Contract. These task orders, ranging in value from $103,046 to $103 million, task ATCC with providing a variety of services including the storage and distribution of biological samples,...

This indefinite delivery contract was awarded to Cellectis Bioresearch Inc. by the National Heart Lung and Blood Institute, a civilian federal agency, to provide professional support services. The contract is a multiple award, with a ceiling value of $6,984,000.00 and a period of performance through September 23, 2015. The contract aims to procure professional support services related to gene insertion and pluripotent stem cell research, as indicated by the parent master IDIQ contract title...

This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA)....

The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...

The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...

This Blanket Purchase Agreement (BPA) was awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The BPA has a ceiling value of $10,000,000 and runs through December 31, 2025. Under this single-award IDV, Stemcell Technologies Inc. will provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $20 billion Indefinite Delivery Contract to Advanced Technology International (ATI), a public service nonprofit, to establish and manage the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-Consortium). The consortium aims to build domestic manufacturing capabilities for medical countermeasures like vaccines, therapeutics, and personal...

The Department of Health and Human Services Food and Drug Administration awarded a blanket purchase agreement to Charles River Laboratories, Inc. to provide various research services including embryo and sperm cryopreservation, housing expansion, and special air freight. Under three call orders against the agreement, Charles River will deliver embryo cryopreservation procedures for $1,500-$2,266.80 each, totaling $36,468, as well as sperm cryopreservation services for $28,565.60. Special air...

This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....